Sporotrichosis: an update

被引:0
作者
Bonifaz, A. [1 ,2 ]
Vazquez-Gonzalez, D. [2 ]
机构
[1] Gen Hosp Mexico, Dept Mycol, Mexico City, DF, Mexico
[2] Gen Hosp Mexico, Dept Dermatol, Mexico City, DF, Mexico
来源
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA | 2010年 / 145卷 / 05期
关键词
Sporotrichosis; Mycosis; Potassium iodide; Itraconazole; RIO-DE-JANEIRO; DISSEMINATED CUTANEOUS SPOROTRICHOSIS; SPOROTHRIX-SCHENCKII; CONJUNCTIVAL SPOROTRICHOSIS; IN-VITRO; LYMPHOCUTANEOUS SPOROTRICHOSIS; ZOONOTIC SPOROTRICHOSIS; BRAZIL; EPIDEMIC; PATIENT;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Sporotrichosis is the most frequent and worldwide distributed subcutaneous mycoses. The aim of this article is to review the most recent aspects of sporotrichosis about its epidemiology, etiologic agents, mycologic characteristics, clinical features, diagnosis and treatment. The causative agents of sporotrichosis belong to five well defined species of dimorphic fungi of the called Sporothrix schenckii complex. Sporotrichosis and its etiologic agents have specific endemic areas, but it is possible to find epidemics of the disease in practically every continent, the entrance via is cutaneous due to the inoculation of the fungi into the skin after a traumatism and less frequent due to respiratory way. Clinical manifestations are widely variable, with important involvement of the skin and the superficial lymphatic system, but also with affection of the mucosa and some organs like lungs, bones and joints. Nowadays sporotrichosis is considered a true zoonosis with important changes related to the endemic areas and the ecologic features of the causative pathogens. The therapy of choice is the Potassium iodide (KI), but other alternatives are itraconazole, terbinafine, thermotherapy and in severe cases amphotericin B. The importance of the recognition of the clinical manifestations of the disease in some non-endemic areas helps to challenge the diagnosis and give an accurate therapy.
引用
收藏
页码:659 / 673
页数:15
相关论文
empty
未找到相关数据